TD2 and Deep 6 AI Announce Partnership

May 31, 2017

Translational Drug Development (TD2) and Deep 6 AI have agreed to collaborate in the fields of oncology and fibrosis.

Translational Drug Development (TD2) and Deep 6 AI have agreed to collaborate in the fields of oncology and fibrosis to match eligible patients with the appropriate clinical trials.

Read the full release here

Related Content:

News